Ionis Pharmaceuticals
IONS
IONS
390 hedge funds and large institutions have $7.29B invested in Ionis Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 116 increasing their positions, 131 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
0.96% less ownership
Funds ownership: 86.79% → 85.83% (-0.96%)
11% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 131
13% less call options, than puts
Call options by funds: $89M | Put options by funds: $103M
Holders
390
Holding in Top 10
6
Calls
$89M
Puts
$103M
Top Buyers
| 1 | +$75.2M | |
| 2 | +$29.4M | |
| 3 | +$25.2M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$22.6M |
| 5 |
JPMorgan Chase & Co
New York
|
+$19.4M |
Top Sellers
| 1 | -$81.8M | |
| 2 | -$60.9M | |
| 3 | -$59.8M | |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
-$23.8M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$23M |